Administration of type a botulinum toxin after total hip replacement

European Journal of Physical and Rehabilitation Medicine

Volumn 44, Issue 4, 2008, Pages 461-465

  Bertoni, M ^a   Castagna, A ^a   Baricich, A ^b,c   Berti, G ^a   Lazzaretti, S ^a   Morandi, C ^a  

^a Loc Trompone ^*  (Italy)

^b Neuromotor Rehabilitation Unit   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Arthroplasty, replacement, hip; Botulinum toxin type A; Muscles; Pain; Rehabilitation

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

AGED; ARTICLE; CASE REPORT; CONTRACTURE; FEMALE; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BOTULINUM TOXIN TYPE A; CONTRACTURE; FEMALE; HUMANS; NEUROMUSCULAR AGENTS; OSTEOARTHRITIS, HIP;

EID: 59649086887     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-7.
2. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-99.
3. Kendall FP, McCreary EK, Provance PG. Muscles: testing and functions. 5th edition. Baltimore: Williams and Wilkins; 1993.
4. Pathak MS, Nguyen HT, Graham HK, Moore AP. Management of spasticity in adults: practical application of botulinum toxin. Eur J Neurol 2006;13(Suppl l):42-50.
5. Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl 1997;6:Sl69-75.
6. Hesse S, Mauritz KH. Management of spasticity. Curr Opin Neurol 1997;10:498-501.
7. Davis EC, Barnes MP. Botulinum toxin and spasticity. J Neurol Neurosurg Psychiatry 2000;69:143-9.
8. Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 2000;69:499-506.
9. Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F et al. Use of botulinum toxin type A in management of adult spasticity: a European consensus statement. J Rehabil Med 2003;35:98-9.
10. Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 2005;20:592-7.
11. Ward A, Roberts G, Warner J, Gillard S. Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity. J Rehabil Med 2005;37:252-7.
12. Placzek R, Sohling M, Gessler M, Jerosch J. Botulinum Toxin A in orthopedic pain therapy. Schmerz 2004;18:498-505.
13. Childers MK, Wilson DJ, Gnatz SM, Conway RR, Sherman AK. Botulinum Toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil 2002;81:751-9.
14. Placzek R, Deuretzbacher G, Buttgereit F, Meiss AL. Treatment of chronic plantar fasciitis with botulinum toxin A: an open case series with a 1 year follow up. Ann Rheum Dis 2005;64:1659-61.
15. Placzek R, Deuretzbacher G, Meiss AL. Treatment of chronic plantar fasciitis with botulinum toxin A: preliminary clinical results. Clin J Pain 2006;22:190-2.
16. Hayton MJ, Santini AJ, Hughes PJ, Frostick SP, Trail IA, Stanley JK. Botulinum toxin injection in the treatment of tennis elbow- a double-blind, randomized, controlled, pilot study. J Bone Joint Surg Am 2005;87:503-7.
17. Wong SM, Hui AC, Tong PY, Poon DW, Yu E, Wong LK. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2005;143:793-7.
18. Keizer SB, Rutten HP, Pilot P, Morre HH, Os JJ, Verburg AD. Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study. Clin Orthop Relat Res 2002;(401):125-31.
19. Ney JP, Difazio M, Sichani A, Monacci W, Foster L, Jabbari B. Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: a prospective trial of 60 patients. Clin J Pain 2006;22:363-9.
20. Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000;42:116-21.
21. Fishman SM. Trigger point definition. American Pain Foundation, July 2004.
22. Monnier G, Tatu L, Michel F. Review: New indications for botulinum toxin in rheumatology. Joint Bone Spine 2006;73:667-71.